Article
Prenatal diagnosis of Apert syndrome caused by a de novo FGFR2 mutation in the second trimester: a case report.
BMC pregnancy and childbirth - 26 May 2026
Chen Xiaoying, Jin Pengzhen, Chen Min, Zuo Juan, Liu Jie, Zhu Jin, Lin Miaochun, Li Zhaohui, Dong Minyue
Abstract excerpt
BACKGROUND: Apert syndrome is a syndromic craniosynostosis primarily caused by pathogenic mutations in the fibroblast growth factor receptor 2 (FGFR2) gene. Current prenatal diagnosis of Apert syndrome predominantly relies on ultrasound imaging in the third trimester (28 weeks of gestation to delivery), which is not conducive to early clinical decision-making. CASE PRESENTATION: In this case, prenatal ultrasound...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
